220 related articles for article (PubMed ID: 31441196)
1. Synthetic cannabinoids and their impact on neurodevelopmental processes.
Alexandre J; Carmo H; Carvalho F; Silva JP
Addict Biol; 2020 Mar; 25(2):e12824. PubMed ID: 31441196
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Cannabinoids: A Pharmacological and Toxicological Overview.
Roque-Bravo R; Silva RS; Malheiro RF; Carmo H; Carvalho F; da Silva DD; Silva JP
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():187-209. PubMed ID: 35914767
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling.
Walsh KB; Andersen HK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854313
[TBL] [Abstract][Full Text] [Related]
4. Advances in urinary biomarker research of synthetic cannabinoids.
Wang Z; Leow EYQ; Moy HY; Chan ECY
Adv Clin Chem; 2023; 115():1-32. PubMed ID: 37673518
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.
Gómez M; Hernández M; Johansson B; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):201-7. PubMed ID: 15068010
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
Tanda G; Goldberg SR
Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
9. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.
Smolyakova AM; Zagzoog A; Brandt AL; Black T; Mohamed K; Laprairie RB
J Clin Neurophysiol; 2020 Jan; 37(1):15-27. PubMed ID: 31895186
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids on the brain.
Irving AJ; Rae MG; Coutts AA
ScientificWorldJournal; 2002 Mar; 2():632-48. PubMed ID: 12805989
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment.
Gomes TM; Dias da Silva D; Carmo H; Carvalho F; Silva JP
Pharmacol Res; 2020 Dec; 162():105237. PubMed ID: 33053442
[TBL] [Abstract][Full Text] [Related]
12. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
Noble C; Cannaert A; Linnet K; Stove CP
Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid exposure during pregnancy and its impact on immune function.
Dong C; Chen J; Harrington A; Vinod KY; Hegde ML; Hegde VL
Cell Mol Life Sci; 2019 Feb; 76(4):729-743. PubMed ID: 30374520
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
16. Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.
Lo JO; Hedges JC; Girardi G
Am J Obstet Gynecol; 2022 Oct; 227(4):571-581. PubMed ID: 35662548
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
de Salas-Quiroga A; Díaz-Alonso J; García-Rincón D; Remmers F; Vega D; Gómez-Cañas M; Lutz B; Guzmán M; Galve-Roperh I
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13693-8. PubMed ID: 26460022
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system and the brain.
Mechoulam R; Parker LA
Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid disruption of learning mechanisms involved in reward processing.
Lupica CR; Hoffman AF
Learn Mem; 2018 Sep; 25(9):435-445. PubMed ID: 30115765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
